S&P 500   3,758.43 (-0.27%)
DOW   30,953.82 (+0.10%)
QQQ   303.04 (-0.35%)
AAPL   119.58 (-0.46%)
MSFT   228.69 (+0.86%)
FB   260.04 (+0.93%)
GOOGL   2,066.34 (+1.59%)
TSLA   588.50 (-5.30%)
AMZN   2,974.49 (-0.10%)
NVDA   486.72 (-1.63%)
BABA   233.88 (+1.47%)
CGC   30.17 (-2.71%)
GE   13.72 (+1.11%)
MU   85.13 (+0.95%)
NIO   36.55 (-6.95%)
AMD   77.22 (-0.68%)
T   29.55 (+2.18%)
F   12.08 (+1.26%)
ACB   9.79 (-0.31%)
DIS   186.91 (-0.60%)
BA   223.88 (-0.37%)
NFLX   505.40 (-1.15%)
BAC   37.12 (+1.70%)
S&P 500   3,758.43 (-0.27%)
DOW   30,953.82 (+0.10%)
QQQ   303.04 (-0.35%)
AAPL   119.58 (-0.46%)
MSFT   228.69 (+0.86%)
FB   260.04 (+0.93%)
GOOGL   2,066.34 (+1.59%)
TSLA   588.50 (-5.30%)
AMZN   2,974.49 (-0.10%)
NVDA   486.72 (-1.63%)
BABA   233.88 (+1.47%)
CGC   30.17 (-2.71%)
GE   13.72 (+1.11%)
MU   85.13 (+0.95%)
NIO   36.55 (-6.95%)
AMD   77.22 (-0.68%)
T   29.55 (+2.18%)
F   12.08 (+1.26%)
ACB   9.79 (-0.31%)
DIS   186.91 (-0.60%)
BA   223.88 (-0.37%)
NFLX   505.40 (-1.15%)
BAC   37.12 (+1.70%)
S&P 500   3,758.43 (-0.27%)
DOW   30,953.82 (+0.10%)
QQQ   303.04 (-0.35%)
AAPL   119.58 (-0.46%)
MSFT   228.69 (+0.86%)
FB   260.04 (+0.93%)
GOOGL   2,066.34 (+1.59%)
TSLA   588.50 (-5.30%)
AMZN   2,974.49 (-0.10%)
NVDA   486.72 (-1.63%)
BABA   233.88 (+1.47%)
CGC   30.17 (-2.71%)
GE   13.72 (+1.11%)
MU   85.13 (+0.95%)
NIO   36.55 (-6.95%)
AMD   77.22 (-0.68%)
T   29.55 (+2.18%)
F   12.08 (+1.26%)
ACB   9.79 (-0.31%)
DIS   186.91 (-0.60%)
BA   223.88 (-0.37%)
NFLX   505.40 (-1.15%)
BAC   37.12 (+1.70%)
S&P 500   3,758.43 (-0.27%)
DOW   30,953.82 (+0.10%)
QQQ   303.04 (-0.35%)
AAPL   119.58 (-0.46%)
MSFT   228.69 (+0.86%)
FB   260.04 (+0.93%)
GOOGL   2,066.34 (+1.59%)
TSLA   588.50 (-5.30%)
AMZN   2,974.49 (-0.10%)
NVDA   486.72 (-1.63%)
BABA   233.88 (+1.47%)
CGC   30.17 (-2.71%)
GE   13.72 (+1.11%)
MU   85.13 (+0.95%)
NIO   36.55 (-6.95%)
AMD   77.22 (-0.68%)
T   29.55 (+2.18%)
F   12.08 (+1.26%)
ACB   9.79 (-0.31%)
DIS   186.91 (-0.60%)
BA   223.88 (-0.37%)
NFLX   505.40 (-1.15%)
BAC   37.12 (+1.70%)
Log in
NASDAQ:NBEV

NewAge Stock Forecast, Price & News

$2.66
-0.01 (-0.37 %)
(As of 03/5/2021 10:12 AM ET)
Add
Compare
Today's Range
$2.62
Now: $2.66
$2.69
50-Day Range
$2.63
MA: $3.19
$4.37
52-Week Range
$0.98
Now: $2.66
$4.55
Volume15,620 shs
Average Volume3.07 million shs
Market Capitalization$320.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.97
New Age Beverages Corporation develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink (RTD) beverages. The company offers RTD tea, coffee, kombucha, energy drinks, relaxation drinks, coconut waters, functional waters, and rehydration beverages, as well as functional medical beverages. It provides its products under the Xing Tea, Marley, Búcha Live Kombucha, Coco-Libre, Evian, Volvic, Tahitian Noni Juice, TruAge, Aspen Pure, PediaAde, Coco Libre, BioShield, and NHANCED brands. The company sells its products across 50 states in the United States; and approximately 60 countries internationally through direct-store-delivery systems, brokers and distributors, warehouses, independent product consultants, and e-commerce sites, as well as through grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, gas stations, and individual independent distributors. New Age Beverages Corporation was founded in 2010 and is headquartered in Denver, Colorado.
NewAge logo

Headlines

Form 8-K NewAge, Inc. For: Mar 03 - StreetInsider.com
March 5, 2021 |  streetinsider.com
Why NewAge Stock Tanked Today - Motley Fool
February 16, 2021 |  fool.com
Why Sesen Bio Stock Is Soaring Today - Nasdaq
February 16, 2021 |  nasdaq.com
NewAge raises $58M in private placement - Seeking Alpha
February 16, 2021 |  seekingalpha.com
NewAge Announces Preliminary Q4 2020 Results - Yahoo Finance
February 16, 2021 |  finance.yahoo.com
NewAge Announces Preliminary Q4 2020 Results
February 16, 2021 |  finance.yahoo.com
NewAge Announces $58 Million Private Placement
February 16, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Malt beverages
Sub-IndustryN/A
Current SymbolNASDAQ:NBEV
CUSIPN/A
Phone303-289-8655
Employees906
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$253.71 million
Book Value$1.18 per share

Profitability

Net Income$-89,830,000.00

Miscellaneous

Market Cap$320.61 million
Next Earnings Date3/16/2021 (Confirmed)
OptionableOptionable

MarketRank

Overall MarketRank

1.19 out of 5 stars

Consumer Staples Sector

140th out of 301 stocks

Malt Beverages Industry

10th out of 15 stocks

Analyst Opinion: 3.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$2.66
-0.01 (-0.37 %)
(As of 03/5/2021 10:12 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NBEV News and Ratings via Email

Sign-up to receive the latest news and ratings for NBEV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NewAge (NASDAQ:NBEV) Frequently Asked Questions

Is NewAge a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NewAge in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NewAge stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBEV, but not buy additional shares or sell existing shares.
View analyst ratings for NewAge
or view top-rated stocks.

What stocks does MarketBeat like better than NewAge?

Wall Street analysts have given NewAge a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NewAge wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is NewAge's next earnings date?

NewAge is scheduled to release its next quarterly earnings announcement on Tuesday, March 16th 2021.
View our earnings forecast for NewAge
.

How can I listen to NewAge's earnings call?

NewAge will be holding an earnings conference call on Tuesday, March 16th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were NewAge's earnings last quarter?

NewAge, Inc. (NASDAQ:NBEV) issued its earnings results on Monday, November, 9th. The company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.08. The company had revenue of $62.72 million for the quarter, compared to analysts' expectations of $70.73 million. NewAge had a negative trailing twelve-month return on equity of 61.13% and a negative net margin of 40.74%.
View NewAge's earnings history
.

How has NewAge's stock price been impacted by COVID-19?

NewAge's stock was trading at $1.72 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NBEV stock has increased by 54.7% and is now trading at $2.66.
View which stocks have been most impacted by COVID-19
.

What guidance has NewAge issued on next quarter's earnings?

NewAge updated its fourth quarter 2020 Pre-Market earnings guidance on Tuesday, February, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $90-90 million, compared to the consensus revenue estimate of $79.34 million.

What price target have analysts set for NBEV?

1 equities research analysts have issued twelve-month price objectives for NewAge's stock. Their forecasts range from $4.00 to $5.00. On average, they anticipate NewAge's share price to reach $4.50 in the next twelve months. This suggests a possible upside of 69.2% from the stock's current price.
View analysts' price targets for NewAge
or view top-rated stocks among Wall Street analysts.

Who are NewAge's key executives?

NewAge's management team includes the following people:
  • Mr. Brent David Willis, CEO & Director (Age 60, Pay $1.02M)
  • Mr. Gregory A. Gould CPA, CPA, Chief Financial Officer (Age 55, Pay $585.82k)
  • Mr. Mark H. Wilson, Group Pres (Age 56)
  • Mr. Riley Timmer, VP of Investor Relations
  • Mr. Michael Cunningham, Sr. VP of Sales
  • Ms. Julie Garlikov, Chief Marketing Officer (Age 50)
  • Mr. Jay Barrow, Head of Brand
  • Mr. Kelly Olsen, Chief Commercial Officer (Age 66)
  • Mr. David Vanderveen, Consultant (Age 52)
  • Dr. Randy L. Looper, Pres of New Age Health Sciences Divisions

Who are some of NewAge's key competitors?

What other stocks do shareholders of NewAge own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NewAge investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Cronos Group (CRON), Advanced Micro Devices (AMD), Micron Technology (MU), NIO (NIO), BHP Group (BHP), (APHA) and General Electric (GE).

What is NewAge's stock symbol?

NewAge trades on the NASDAQ under the ticker symbol "NBEV."

Who are NewAge's major shareholders?

NewAge's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.47%), Northern Trust Corp (0.85%), Nuveen Asset Management LLC (0.32%), Bank of New York Mellon Corp (0.25%), Dimensional Fund Advisors LP (0.25%) and Charles Schwab Investment Management Inc. (0.20%). Company insiders that own NewAge stock include Brent D Willis, Reginald Kapteyn and Timothy J Haas.
View institutional ownership trends for NewAge
.

Which institutional investors are selling NewAge stock?

NBEV stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Northern Trust Corp, and International Assets Investment Management LLC.
View insider buying and selling activity for NewAge
or view top insider-selling stocks.

Which institutional investors are buying NewAge stock?

NBEV stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Dimensional Fund Advisors LP, JPMorgan Chase & Co., Squarepoint Ops LLC, Davy Global Fund Management Ltd, Virtu Financial LLC, Bank of New York Mellon Corp, and Nisa Investment Advisors LLC.
View insider buying and selling activity for NewAge
or or view top insider-buying stocks.

How do I buy shares of NewAge?

Shares of NBEV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NewAge's stock price today?

One share of NBEV stock can currently be purchased for approximately $2.66.

How much money does NewAge make?

NewAge has a market capitalization of $320.61 million and generates $253.71 million in revenue each year. The company earns $-89,830,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis.

How many employees does NewAge have?

NewAge employs 906 workers across the globe.

What is NewAge's official website?

The official website for NewAge is newagebev.us.

Where are NewAge's headquarters?

NewAge is headquartered at 2420 17TH STREET SUITE 220, DENVER CO, 80202.

How can I contact NewAge?

NewAge's mailing address is 2420 17TH STREET SUITE 220, DENVER CO, 80202. The company can be reached via phone at 303-289-8655 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.